Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EPZM

Epizyme (EPZM) Stock Price, News & Analysis

Epizyme logo

About Epizyme Stock (NASDAQ:EPZM)

Advanced Chart

Key Stats

Today's Range
$1.47
$1.47
50-Day Range
$1.47
$1.52
52-Week Range
$0.41
$5.80
Volume
7,960 shs
Average Volume
3.23 million shs
Market Capitalization
$247.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EPZM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epizyme and its competitors with MarketBeat's FREE daily newsletter.

EPZM Stock News Headlines

bluebird bio Inc BLUE
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
Epizyme: Q2 Earnings Insights - Benzinga
See More Headlines

EPZM Stock Analysis - Frequently Asked Questions

Epizyme, Inc. (NASDAQ:EPZM) released its earnings results on Tuesday, November, 9th. The biopharmaceutical company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.48) by $0.16. The company's revenue was up 45.8% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Epizyme investors own include Novavax (NVAX), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Pfizer (PFE), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/09/2021
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EPZM
Employees
250
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$251.12 million
Net Margins
-391.90%
Pretax Margin
-391.80%

Debt

Sales & Book Value

Annual Sales
$37.43 million
Price / Cash Flow
N/A
Book Value
($0.54) per share
Price / Book
-2.72

Miscellaneous

Free Float
128,968,000
Market Cap
$247.44 million
Optionable
Optionable
Beta
-0.41

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:EPZM) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners